Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

Published:2017-01-10 Issue:2 Volume:317 Page:156
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Block Geoffrey A.¹,Bushinsky David A.²,Cheng Sunfa³,Cunningham John⁴,Dehmel Bastian³,Drueke Tilman B.⁵,Ketteler Markus⁶,Kewalramani Reshma³,Martin Kevin J.⁷,Moe Sharon M.⁸,Patel Uptal D.⁹,Silver Justin¹⁰,Sun Yan³,Wang Hao³,Chertow Glenn M.¹¹

Affiliation:

1. Denver Nephrology, Denver, Colorado

2. University of Rochester, Rochester, New York

3. Amgen Inc, Thousand Oaks, California

4. University College London, London, United Kingdom

5. Inserm, Université de Picardie, Amiens, France

6. Klinikum Coburg-GmbH, Coburg, Germany

7. St Louis University, St Louis, Missouri

8. Indiana University, Indianapolis

9. Duke University, Durham, North Carolina

10. Hadassah Hebrew University Medical Center, Jerusalem, Israel

11. Stanford University, Stanford, California

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Persistent uncertainties in optimal treatment approaches of secondary hyperparathyroidism and hyperphosphatemia in patients with chronic kidney disease;Current Osteoporosis Reports;2024-08-19

2. The mechanisms underlying acute myocardial infarction in chronic kidney disease patients undergoing hemodialysis;Biomedicine & Pharmacotherapy;2024-08

3. Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease;Bone;2024-08

4. Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis;European Journal of Clinical Pharmacology;2024-07-13

5. Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration;BMJ;2024-07-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3